<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Preseptal cellulitis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Preseptal cellulitis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Preseptal cellulitis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Christopher Gappy, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steven M Archer, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marlene L Durand, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Deborah S Jacobs, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 28, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H83430247"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Preseptal cellulitis (sometimes called periorbital cellulitis) is an infection of the anterior portion of the eyelid, not involving the orbit or other ocular structures. In contrast, orbital cellulitis is an infection involving the contents of the orbit (fat and ocular muscles) but not the globe. Although preseptal and orbital cellulitis may be confused with one another because both can cause ocular pain and eyelid swelling and erythema, they have very different clinical implications. Preseptal cellulitis is generally a mild condition that rarely leads to serious complications, whereas orbital cellulitis may cause loss of vision and even loss of life. Orbital cellulitis can usually be distinguished from preseptal cellulitis by its clinical features (ophthalmoplegia, pain with eye movements, impaired visual acuity, and proptosis) (<a class="graphic graphic_table graphicRef55123" href="/z/d/graphic/55123.html" rel="external">table 1</a>) and by imaging studies. In cases in which the distinction is not clear, clinicians should treat patients as though they have orbital cellulitis. Both conditions are more common in children than in adults, and preseptal cellulitis is much more common than orbital cellulitis. </p><p>The pathogenesis, microbiology, clinical manifestations, diagnosis, and treatment of preseptal cellulitis will be reviewed here. Orbital cellulitis, subperiosteal abscess, and orbital abscess, are discussed separately. Orbital infections caused by fungi, mainly the <em>Mucorales</em> (which cause mucormycosis) and <em>Aspergillus</em> spp and, much more rarely, <em>Mycobacterium tuberculosis</em>, are also presented elsewhere. (See  <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">"Orbital cellulitis"</a> and  <a class="medical medical_review" href="/z/d/html/2465.html" rel="external">"Mucormycosis (zygomycosis)"</a> and  <a class="medical medical_review" href="/z/d/html/2454.html" rel="external">"Epidemiology and clinical manifestations of invasive aspergillosis"</a> and  <a class="medical medical_review" href="/z/d/html/7999.html" rel="external">"Tuberculosis and the eye"</a>.)</p><p class="headingAnchor" id="H83430254"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>Preseptal cellulitis and orbital cellulitis involve different anatomic sites, with preseptal cellulitis referring to infections of the soft tissues anterior to the orbital septum and orbital cellulitis referring to infections posterior to it (<a class="graphic graphic_figure graphicRef68971" href="/z/d/graphic/68971.html" rel="external">figure 1</a>). Neither infection involves the globe. (See <a class="local">'Anatomy'</a> below.)</p><p>There is some debate regarding the appropriate terminology for these infections. Some clinicians use the term "periorbital cellulitis" rather than "preseptal cellulitis" or use the terms interchangeably. We prefer the term "preseptal cellulitis" to make a clear anatomic distinction between this infection and the more serious infection, "orbital cellulitis." Orbital cellulitis is sometimes referred to as "postseptal cellulitis"; we favor the term "orbital cellulitis," and will use it throughout this topic.</p><p class="headingAnchor" id="H83430261"><span class="h1">ANATOMY</span><span class="headingEndMark"> — </span>Basic familiarity with the anatomy of the eye is fundamental to understanding the pathogenesis, clinical manifestations, and complications of preseptal and orbital cellulitis. The orbit is a cone-shaped structure, lying horizontally, with its apex in the skull. It is surrounded by paranasal sinuses, namely, the frontal (lying superior), ethmoid (medial) and maxillary (inferior) sinuses (<a class="graphic graphic_figure graphicRef71411" href="/z/d/graphic/71411.html" rel="external">figure 2</a>). The orbit is lined by periosteum. The ethmoid sinuses are separated from the orbit by a paper-thin layer called the lamina papyracea, which contains many perforations for nerves and blood vessels as well as some natural fenestrations termed Zuckerkandl's dehiscences. The most common route of infection to the orbit is by extension from the ethmoid sinuses, likely facilitated through these perforations. </p><p>The orbital septum is a membranous sheet that extends from the periosteum of the orbit to the tarsal plate and forms the anterior boundary of the orbital compartment (<a class="graphic graphic_figure graphicRef68971" href="/z/d/graphic/68971.html" rel="external">figure 1</a>). As noted above, preseptal cellulitis involves the soft tissues anterior to the orbital septum. </p><p class="headingAnchor" id="H234333111"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Preseptal cellulitis is much more common than orbital cellulitis. In two pediatric case series, 94 percent and 87 percent of cases, respectively, were diagnosed as preseptal cellulitis [<a href="#rid1">1,2</a>]; the remainder of cases were diagnosed as orbital cellulitis. Both infections are much more common in children than in adults; accordingly, most of the data regarding these infections come from studies in children. </p><p>It is important to distinguish between preseptal and orbital cellulitis because the complications, treatments, and outcomes of the two entities are very different. (See <a class="local">'Clinical manifestations'</a> below.)</p><p class="headingAnchor" id="H83430756"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Whereas the paranasal sinuses are the main source of infection in orbital cellulitis, a number of preseptal cellulitis cases arise from alternative sources. In one retrospective series of 315 children admitted to the hospital with preseptal or orbital cellulitis, sinusitis was the underlying condition in all 18 children with orbital cellulitis but in only 15 percent of those with preseptal cellulitis [<a href="#rid1">1</a>]. However, other studies have found sinusitis to be the most common cause of preseptal cellulitis [<a href="#rid3">3,4</a>]. </p><p>Other sites from which preseptal cellulitis may arise are the surrounding skin and soft tissues of the face and eyelids. These tissues may become infected following bacteremia or local trauma [<a href="#rid5">5,6</a>] due to insect bites [<a href="#rid6">6</a>], animal bites [<a href="#rid7">7</a>], or foreign bodies. In one retrospective series of 104 patients with preseptal cellulitis admitted to a tertiary care center, roughly 30 percent were thought to originate from each of the following causes: acute dacryocystitis, sinusitis or upper respiratory tract infection, or trauma (including recent eyelid or strabismus surgery) [<a href="#rid8">8</a>]. In another retrospective study that included 262 children with preseptal or orbital cellulitis, trauma (including insect bites) was much more common in patients with preseptal cellulitis than in those with orbital cellulitis (40 versus 11 percent) [<a href="#rid2">2</a>]. Bacteremic seeding of the preseptal space was more common in the era before the availability of the conjugate vaccines for <em>Haemophilus influenzae</em> type b and <em>Streptococcus pneumoniae</em>. It is still occasionally seen in infants or children with bacteremia due to <em>Streptococcus pyogenes</em>. <em>Pseudomonas aeruginosa</em> bacteremia is rarely associated with preseptal cellulitis in immunocompromised patients [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H83430763"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>Data concerning the microbiology of preseptal cellulitis relate to the site of primary infection. Blood cultures are almost always negative except in the unusual cases of bacteremic preseptal cellulitis. Infections arising from the sinuses or the nasopharynx are likely to be caused by <em>S. pneumoniae</em>, <em>Moraxella catarrhalis</em>, and <em>H. influenzae</em>. In cases due to local skin or skin structure infection (impetigo, cellulitis, or hordeolum) or dacryocystitis, the most common organisms are <em>Staphylococcus aureus</em> and <em>Streptococcus pyogenes</em>. The proportion due to methicillin-resistant <em>S. aureus</em> will vary by age and community to some extent and it is useful to have antibiotic resistance profiles from local communities as a guide to initiating empiric antimicrobials. (See <a class="local">'Choice of outpatient antibiotic'</a> below.) </p><p>Although <em>H. influenzae</em> type b was previously a common cause of bacteremic preseptal infection in young children, routine immunization of children with the <em>H. influenzae</em> type b vaccine has caused a sharp decline in the incidence of this species as a cause of preseptal cellulitis [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/8048.html" rel="external">"Epidemiology, clinical manifestations, diagnosis, and treatment of <i>Haemophilus influenzae</i>"</a>.)</p><p>Infrequent causes of preseptal cellulitis include <em>Acinetobacter</em> species [<a href="#rid10">10,11</a>], <em>Nocardia brasiliensis</em> [<a href="#rid12">12</a>], <em>Bacillus anthracis</em> [<a href="#rid13">13</a>], <em>Pseudomonas aeruginosa</em> [<a href="#rid9">9</a>], <em>Neisseria gonorrhoeae</em> [<a href="#rid14">14</a>], <em>Proteus</em> spp [<a href="#rid15">15</a>], <em>Pasteurella multocida </em>[<a href="#rid7">7</a>], <em>Mycobacterium tuberculosis</em> [<a href="#rid16">16</a>], and <em>Trichophyton</em> spp (the cause of "ringworm") [<a href="#rid17">17</a>]. These pathogens can usually be linked to specific exposures.</p><p class="headingAnchor" id="H83430770"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Patients with preseptal cellulitis typically present with unilateral ocular pain, eyelid swelling, and erythema (<a class="graphic graphic_picture graphicRef57604" href="/z/d/graphic/57604.html" rel="external">picture 1</a>). </p><p>Chemosis (conjunctival swelling) may occasionally occur in severe cases of preseptal cellulitis but is uncommon. Leukocytosis may also occur in patients with preseptal cellulitis, but is not a sensitive indicator of this infection. The clinical manifestations of preseptal cellulitis should be distinguished from those of orbital cellulitis (<a class="graphic graphic_table graphicRef55123" href="/z/d/graphic/55123.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef62818" href="/z/d/graphic/62818.html" rel="external">table 2</a>), which are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">"Orbital cellulitis", section on 'Clinical manifestations'</a>.)</p><p>Serious complications are rare in preseptal cellulitis. Reported complications include eyelid necrosis and amblyopia associated with delayed resolution of periorbital swelling [<a href="#rid8">8,18</a>]. However, some experts believe that sinusitis-related causes of preseptal and orbital cellulitis represent a continuum and that inappropriately treated preseptal cellulitis can progress to orbital cellulitis. Therefore, clinicians must be vigilant about treatment of preseptal cellulitis. (See <a class="local">'Diagnosis'</a> below and  <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">"Orbital cellulitis", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H408229749"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The main clinical condition to distinguish from preseptal cellulitis is the more serious orbital cellulitis (<a class="graphic graphic_table graphicRef55123" href="/z/d/graphic/55123.html" rel="external">table 1</a>). This is discussed in detail elsewhere. (See <a class="local">'Diagnosis'</a> below.)</p><p>A local allergic reaction (eg, to a topical ophthalmic antibiotic or to the sting of an insect) can also have a similar appearance to preseptal cellulitis but can usually be differentiated by the exposure history. Blunt trauma to the eye may also cause eye swelling but the history should reveal the diagnosis. Periorbital swelling from environmental allergies, angioedema, or congestive heart failure is usually bilateral (in contrast to preseptal cellulitis, which is usually unilateral).</p><p>Other superficial periorbital processes are typically visually distinct from preseptal cellulitis. Hordeolum (stye) and chalazion can be associated with eyelid inflammation, but are usually discrete nodular lesions (see  <a class="medical medical_review" href="/z/d/html/6898.html" rel="external">"Eyelid lesions", section on 'Hordeolum (stye)'</a> and  <a class="medical medical_review" href="/z/d/html/6898.html" rel="external">"Eyelid lesions", section on 'Chalazion'</a>). Occasionally, an internal hordeolum points to the conjunctival surface of the eye and causes a diffuse rather than a localized swelling. Examination of the underside of the lid for the presence of a hordeolum helps distinguish this entity from more serious causes of eye swelling. Conjunctivitis can rarely cause eyelid edema, but conjunctival findings (eg, injection and irritation) clearly distinguish this from preseptal cellulitis. (See  <a class="medical medical_review" href="/z/d/html/6907.html" rel="external">"Conjunctivitis", section on 'Classification and epidemiology'</a>.)</p><p class="headingAnchor" id="H83430777"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Preseptal cellulitis is usually a clinical diagnosis, made in a patient with eyelid swelling and erythema once orbital cellulitis has been excluded. Exclusion of orbital cellulitis is dependent on the absence of proptosis, ophthalmoplegia, pain on eye movement, and impairment of visual acuity (<a class="graphic graphic_table graphicRef55123" href="/z/d/graphic/55123.html" rel="external">table 1</a>). Rarely, imaging may be necessary in uncertain cases. </p><p class="headingAnchor" id="H3623562543"><span class="h2">Clinical evaluation and diagnosis</span><span class="headingEndMark"> — </span>Preseptal cellulitis is suspected in patients with unilateral eyelid swelling and erythema (<a class="graphic graphic_picture graphicRef57604" href="/z/d/graphic/57604.html" rel="external">picture 1</a>). A history of recent sinusitis (or prolonged/worsening upper respiratory symptoms), insect bite, or local face and/or eyelid trauma is supportive of the diagnosis. The most important aspect of the diagnostic evaluation is distinguishing preseptal cellulitis from the more severe orbital cellulitis (<a class="graphic graphic_table graphicRef55123" href="/z/d/graphic/55123.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef62818" href="/z/d/graphic/62818.html" rel="external">table 2</a>), as these different infections have very different clinical implications [<a href="#rid2">2,19-22</a>]. (See  <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">"Orbital cellulitis", section on 'Diagnosis'</a>.)</p><p>Findings that should raise concern for orbital rather than preseptal cellulitis include ophthalmoplegia with diplopia, pain with eye movement, visual impairment, and proptosis. This is because orbital cellulitis causes swelling and inflammation of the extraocular muscles and fatty tissues within the orbit, but preseptal cellulitis does not. Although chemosis can rarely occur in severe cases of preseptal cellulitis, it is more commonly suggestive of orbital cellulitis. The absence of fever suggests preseptal cellulitis, although patients with orbital cellulitis are sometimes afebrile. As an example, in a retrospective study that included 262 children, fever occurred more commonly in those with orbital cellulitis than in those with preseptal cellulitis (94 versus 47 percent) [<a href="#rid2">2</a>]. </p><p>These clinical features usually allow for a reasonable degree of confidence in distinguishing between the two entities. However, the clinical evaluation can be challenging in young children, who may not be able to cooperate with a full examination. In uncertain cases, computed tomography (CT) scanning of the orbits and sinuses is used to distinguish preseptal cellulitis from orbital cellulitis. (See <a class="local">'Imaging studies'</a> below.) </p><p>If the distinction between the two remains uncertain following evaluation, patients should be managed as though they have orbital cellulitis. (See  <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">"Orbital cellulitis", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">"Orbital cellulitis", section on 'Treatment'</a>.)</p><p class="headingAnchor" id="H3761391380"><span class="h2">Laboratory testing</span><span class="headingEndMark"> — </span>Laboratory testing is generally unnecessary for patients with preseptal cellulitis. We suggest that blood cultures <strong>not</strong> be routinely performed, as the yield in this setting is extremely low. However, blood cultures are reasonable in very young patients, patients with fever, children who are unimmunized, and in cases in which the possibility of bacteremic preseptal cellulitis or orbital cellulitis cannot be reasonably excluded. </p><p class="headingAnchor" id="H83430784"><span class="h2">Imaging studies</span><span class="headingEndMark"> — </span>Contrast-enhanced CT scanning of the orbits and sinuses is helpful for distinguishing between preseptal and orbital cellulitis and is indicated if any clinical signs or symptoms point to orbital cellulitis rather than preseptal cellulitis (<a class="graphic graphic_table graphicRef55123" href="/z/d/graphic/55123.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef62818" href="/z/d/graphic/62818.html" rel="external">table 2</a>). CT imaging is also indicated in patients with presumed preseptal cellulitis who exhibit marked eyelid swelling, fever, and leukocytosis, or whose infection fails to show improvement after 24 to 48 hours of appropriate antibiotics.</p><p>Imaging findings of preseptal cellulitis demonstrate swelling of the eyelid(s) but no proptosis, no fat stranding of the orbital contents, and no edema of the extraocular muscles. Sinusitis is a common cause of preseptal cellulitis and is present in most cases of orbital cellulitis; if sinusitis is identified, the possibility of orbital cellulitis must be given careful consideration (see  <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">"Orbital cellulitis", section on 'Diagnosis'</a>). It is important to note that in some cases of orbital cellulitis, the CT scan abnormalities may be subtle. Imaging studies in patients with suspected orbital cellulitis are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">"Orbital cellulitis", section on 'Imaging studies'</a>.)</p><p class="headingAnchor" id="H83430791"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H1424685852"><span class="h2">Assessing whether inpatient versus outpatient care is appropriate</span><span class="headingEndMark"> — </span>Hospitalization is recommended for any of the following: </p><p class="bulletIndent1"><span class="glyph">●</span>Children younger than one year of age</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children who cannot cooperate fully for an examination</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who are severely ill </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with subtle clinical and/or radiographic findings suggesting that the orbit is involved (<a class="graphic graphic_table graphicRef55123" href="/z/d/graphic/55123.html" rel="external">table 1</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who fail to respond to initial outpatient therapy in 24 to 48 hours (see <a class="local">'Response to therapy'</a> below)</p><p></p><p>Other patients are typically managed in the outpatient setting.</p><p class="headingAnchor" id="H2387132590"><span class="h2">Patients who require hospitalization</span><span class="headingEndMark"> — </span>Patients with indications for hospitalization should initially be managed according to recommendations for orbital cellulitis until orbital cellulitis can be excluded. (See  <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">"Orbital cellulitis", section on 'Treatment'</a>.)</p><p class="headingAnchor" id="H346217816"><span class="h2">Patients who can be managed in the outpatient setting</span><span class="headingEndMark"> — </span>Adults and children older than one year of age with mild preseptal cellulitis and no signs of systemic toxicity can generally be treated as outpatients with oral antibiotics provided that close follow-up can be ensured. Indications for hospitalization are discussed above. (See <a class="local">'Assessing whether inpatient versus outpatient care is appropriate'</a> above.) </p><p class="headingAnchor" id="H2181609578"><span class="h3">Choice of outpatient antibiotic</span><span class="headingEndMark"> — </span>Treatment is almost always empiric and based upon knowledge of the common infecting organisms (<em>S. aureus </em>and <em>S. pyogenes </em>when skin and skin structures are thought to be primary sites of infection and <em>H. influenzae,</em> <em>S. pneumoniae,</em> and <em>M. catarrhalis</em> when sinusitis is thought to be the site of infection) and their usual susceptibility patterns, as blood cultures are rarely positive and cultures from the site of infection are difficult to obtain. </p><p>The approach to selection of an outpatient antimicrobial regimen depends on the presumed pathogenesis of preseptal cellulitis. </p><p class="headingAnchor" id="H4067661757"><span class="h4">Absence of periorbital skin trauma</span><span class="headingEndMark"> — </span>In the absence of trauma (eg, insect bite, skin abrasion, blunt trauma), organisms colonizing the sinuses and nasopharynx are likely to be the cause of infection. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial treatment</strong> – We suggest empiric monotherapy with amoxicillin-clavulanic acid. Although amoxicillin-clavulanic acid is not active against methicillin-resistant<em> S. aureus</em> (MRSA), MRSA is uncommon in this setting, so initial empiric therapy against MRSA is not indicated. </p><p></p><p class="bulletIndent1">In children, usual dosing is 45 mg/kg per day divided every 12 hours; dosing for severe infections or when penicillin-resistant <em>S. pneumoniae </em>is a concern (using the 600 mg/5 mL suspension) is 90 mg/kg per day divided every 12 hours. In adults, we administer 875 mg every 12 hours of the immediate release tablet or 2 g every 12 hours of the extended release tablet. </p><p></p><p class="bulletIndent1">In patients with a nonserious penicillin allergy, a second- or third-generation cephalosporin such as <a class="drug drug_general" data-topicid="9230" href="/z/d/drug information/9230.html" rel="external">cefuroxime</a>, <a class="drug drug_general" data-topicid="9224" href="/z/d/drug information/9224.html" rel="external">cefpodoxime</a>, or <a class="drug drug_general" data-topicid="8602" href="/z/d/drug information/8602.html" rel="external">cefdinir</a> is appropriate. For those with life-threatening allergic reactions, initial empiric therapy should be <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">levofloxacin</a>.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9224" href="/z/d/drug information/9224.html" rel="external">Cefpodoxime</a> (in children &lt;12 years of age: 10 mg/kg per day divided every 12 hours, usual maximum dose 200 mg; in children ≥12 years and adolescents: 400 mg every 12 hours; in adults: 400 mg every 12 hours)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9230" href="/z/d/drug information/9230.html" rel="external">Cefuroxime</a> (in children: 20 to 30 mg/kg per day orally divided every 12 hours (maximum daily dose 1000); in adults: 500 mg orally twice daily) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="8602" href="/z/d/drug information/8602.html" rel="external">Cefdinir</a> (in children: 14 mg/kg per day, divided every 12 or every 24 hours, maximum daily dose 600 mg; in adults: 300 mg twice daily)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">Levofloxacin</a> (in children: 10 to 20 mg/kg per day orally divided every 12 to 24 hours (maximum daily dose 500 mg); in adults: 500 mg orally once daily) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>If no clinical improvement</strong> – If there is minimal or no clinical improvement within 24 to 48 hours, therapy against MRSA should be added. (See <a class="local">'Response to therapy'</a> below and <a class="local">'Presence or recent history of periorbital skin trauma'</a> below.)</p><p></p><p class="headingAnchor" id="H956380422"><span class="h4">Presence or recent history of periorbital skin trauma</span><span class="headingEndMark"> — </span>In the presence of or recent history of periorbital skin trauma (eg, insect bite, skin abrasion, blunt trauma), <em>S. aureus</em> and <em>S. pyogenes</em> are the common causes of infection. </p><p>Due to the prevalence of community-acquired MRSA, patients with a likely <em>S. aureus</em> infection warrant initial empiric therapy against MRSA. Options include: </p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10283" href="/z/d/drug information/10283.html" rel="external">Linezolid</a> (children &lt;5 years: 10 mg/kg/dose orally every 8 hours; children 5 to 11 years: 10 mg/kg/dose orally every 12 hours; children ≥12 years and adults: 600 mg orally every 12 hours) </p><p></p><p class="bulletIndent1"><strong>or</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">Trimethoprim-sulfamethoxazole</a> (TMP-SMX; in children: 8 to 12 mg/kg per day of the TMP component divided every 12 hours; in adults: one to two double-strength tablets [each tablet contains 160 mg TMP and 800 mg SMX] every 12 hours) </p><p></p><p class="bulletIndent1"><strong>plus</strong> <strong>one of the following agents</strong> (which have activity against group A streptococci and <em>H. influenzae</em>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Amoxicillin-clavulanic acid (in children: 90 mg/kg per day divided every 12 hours [using the 600 mg/5 mL suspension]; in adults: 875 mg every 12 hours)</p><p></p><p class="bulletIndent2"><strong>or</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9224" href="/z/d/drug information/9224.html" rel="external">Cefpodoxime</a> (in children &lt;12 years of age: 10 mg/kg per day divided every 12 hours, usual maximum dose 200 mg; in children ≥12 years and adolescents: 400 mg every 12 hours; in adults: 400 mg every 12 hours)</p><p></p><p class="bulletIndent2"><strong>or</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="8602" href="/z/d/drug information/8602.html" rel="external">Cefdinir</a> (in children: 14 mg/kg per day, divided every 12 or every 24 hours, maximum daily dose 600 mg; in adults: 300 mg twice daily)</p><p></p><p class="bulletIndent2"><strong>or</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9230" href="/z/d/drug information/9230.html" rel="external">Cefuroxime</a> (in children: 20 to 30 mg/kg per day orally divided every 12 hours (maximum daily dose 1000); in adults: 500 mg orally twice daily)</p><p></p><p>If drainage will accompany the medical therapy and pathogen identification and susceptibility are known, antibiotics may be changed to target the known causative pathogen. </p><p><a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">Clindamycin</a> is not recommended for empiric treatment of preseptal cellulitis because a substantial number of both MRSA and methicillin susceptible <em>S. aureus</em> are resistant to clindamycin. </p><p>There are no randomized trials comparing the efficacy of antibiotic regimens, thus, the choice among them depends on factors such as potential allergies, toxicities, drug interactions, cost, availability, and clinician familiarity with the medications. </p><p>Topical antibiotics have no role in the treatment of this infection. </p><p class="headingAnchor" id="H83430805"><span class="h3">Response to therapy</span><span class="headingEndMark"> — </span>Preseptal cellulitis typically responds rapidly and completely to appropriate antibiotics. Outpatients who worsen over 24 hours or fail to show signs of improvement in 24 to 48 hours should generally be hospitalized, treated with broad-spectrum intravenous antibiotics, undergo a computed tomography scan to evaluate for orbital cellulitis and its complications, and be seen in consultation by an ophthalmologist. (See  <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">"Orbital cellulitis", section on 'Treatment'</a>.)</p><p class="headingAnchor" id="H83430812"><span class="h3">Duration</span><span class="headingEndMark"> — </span>We generally suggest a duration of five to seven days, but if signs of cellulitis persist at the end of this period, treatment should be continued until the eyelid erythema and swelling have resolved or nearly resolved [<a href="#rid23">23,24</a>]. Treatment recommendations are based on small case series, as there are no controlled trials evaluating the duration of antimicrobial therapy in preseptal cellulitis. </p><p class="headingAnchor" id="H83430819"><span class="h2">Patients with recurrent preseptal cellulitis</span><span class="headingEndMark"> — </span>Preseptal cellulitis rarely recurs. When it does, it is usually due to an underlying cause that has not been diagnosed (eg, allergies, chronic sinusitis) [<a href="#rid25">25,26</a>], and treatment involves addressing this issue. </p><p>A case series of six patients with recurrent preseptal cellulitis, defined as three or more episodes within a one year period with complete resolution between episodes, identified the underlying cause in two patients as environmental allergies, and in one patient each as recurrent sinusitis, herpes simplex infection, contact dermatitis to cosmetics, and Munchausen’s syndrome [<a href="#rid25">25</a>]. An anatomic abnormality of the ethmoid sinuses may also predispose to recurrent preseptal cellulitis [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H83431329"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preseptal versus orbital cellulitis</strong> – Preseptal cellulitis refers to infection of the soft tissues <strong>anterior</strong> to the orbital septum while orbital cellulitis refers to an infection <strong>posterior</strong> to it (<a class="graphic graphic_figure graphicRef68971" href="/z/d/graphic/68971.html" rel="external">figure 1</a>). Preseptal cellulitis is generally a mild condition that rarely leads to serious complications, whereas orbital cellulitis may cause loss of vision and, very rarely, even loss of life. Orbital cellulitis can usually be distinguished from preseptal cellulitis by its clinical features (ophthalmoplegia, pain with eye movements, and proptosis) and by imaging studies (<a class="graphic graphic_table graphicRef55123" href="/z/d/graphic/55123.html" rel="external">table 1</a>); in cases in which the distinction is not clear, clinicians should treat patients as though they have orbital cellulitis. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – Preseptal cellulitis arises most commonly from sinusitis or a contiguous infection of the soft tissues of the face and eyelids secondary to local trauma, insect or animal bites, or foreign bodies. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology </strong>– The causes of preseptal cellulitis are dependent on the underlying pathogenesis (infection of the sinuses versus infection of the skin and skin structures surrounding the eye). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>Staphylococcus aureus</em> (including community-acquired methicillin-resistant <em>S. aureus</em> [MRSA]) and <em>Streptococcus pyogenes </em>are the most common pathogens related to infection of the skin and skin structures (<a class="graphic graphic_table graphicRef77104" href="/z/d/graphic/77104.html" rel="external">table 3</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>Haemophilus influenzae, Streptococcus</em> <em>pneumoniae, </em>and<em> Moraxella catarrhalis </em>are the most common pathogens related to sinusitis (<a class="graphic graphic_table graphicRef77104" href="/z/d/graphic/77104.html" rel="external">table 3</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> – Patients with preseptal cellulitis typically present with unilateral ocular pain, eyelid swelling, and erythema (<a class="graphic graphic_picture graphicRef57604" href="/z/d/graphic/57604.html" rel="external">picture 1</a>). During the initial evaluation, it is critical to distinguish preseptal cellulitis from the more serious orbital cellulitis (<a class="graphic graphic_table graphicRef55123" href="/z/d/graphic/55123.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef62818" href="/z/d/graphic/62818.html" rel="external">table 2</a>). Although both preseptal cellulitis and orbital cellulitis typically cause eyelid swelling and erythema, the presence of ophthalmoplegia, pain with eye movements, chemosis, and/or proptosis occur with orbital cellulitis, but not with preseptal cellulitis. (See <a class="local">'Clinical manifestations'</a> above and <a class="local">'Clinical evaluation and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis can usually be made based on these clinical features. However, in uncertain cases, computed tomography scanning of the orbits and sinuses can usually distinguish preseptal cellulitis from orbital cellulitis. (See <a class="local">'Imaging studies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Adults and children older than one year of age with mild preseptal cellulitis can be managed on an outpatient basis, provided that the patient has no signs of systemic toxicity and close follow-up is ensured. Hospitalization is recommended for any of the following and such patients should generally be managed according to the recommendations for orbital cellulitis until it is excluded. (See  <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">"Orbital cellulitis", section on 'Treatment'</a>.): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Children younger than one year of age</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Children who cannot cooperate fully for an examination</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients who are severely ill </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with subtle clinical and/or radiographic findings suggesting that the orbit is involved </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients who fail to respond to initial outpatient therapy in 24 to 48 hours</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antibiotic selection</strong>  </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients with absence of skin trauma in the periorbital region, we suggest monotherapy with amoxicillin-clavulanic acid (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Alternatives include <a class="drug drug_general" data-topicid="9224" href="/z/d/drug information/9224.html" rel="external">cefpodoxime</a>, <a class="drug drug_general" data-topicid="9230" href="/z/d/drug information/9230.html" rel="external">cefuroxime</a>, <a class="drug drug_general" data-topicid="8602" href="/z/d/drug information/8602.html" rel="external">cefdinir</a>, and in cases of severe penicillin allergies, <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">levofloxacin</a>. (See <a class="local">'Absence of periorbital skin trauma'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients with presence or recent history of skin trauma in the periorbital region, we suggest therapy with activity against <em>S. aureus</em> (including MRSA) and streptococci (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). We use therapy with <a class="drug drug_general" data-topicid="10283" href="/z/d/drug information/10283.html" rel="external">linezolid</a> alone or <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> <strong>plus</strong> one of the following agents: amoxicillin-clavulanic acid, <a class="drug drug_general" data-topicid="9224" href="/z/d/drug information/9224.html" rel="external">cefpodoxime</a>, <a class="drug drug_general" data-topicid="9230" href="/z/d/drug information/9230.html" rel="external">cefuroxime</a>, or <a class="drug drug_general" data-topicid="8602" href="/z/d/drug information/8602.html" rel="external">cefdinir</a>. (See <a class="local">'Presence or recent history of periorbital skin trauma'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Duration of therapy</strong> – We generally administer antibiotics for five to seven days, but if signs of cellulitis persist at the end of this period, treatment should be continued until the erythema and swelling have resolved or nearly resolved. (See <a class="local">'Duration'</a> above and  <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">"Orbital cellulitis", section on 'Treatment'</a>.)</p><p></p><p class="headingAnchor" id="H1470624365"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate would like to acknowledge Michael Barza, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Ambati BK, Ambati J, Azar N, et al. Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination. Ophthalmology 2000; 107:1450.</a></li><li><a class="nounderline abstract_t">Botting AM, McIntosh D, Mahadevan M. Paediatric pre- and post-septal peri-orbital infections are different diseases. A retrospective review of 262 cases. Int J Pediatr Otorhinolaryngol 2008; 72:377.</a></li><li><a class="nounderline abstract_t">Mills RP, Kartush JM. Orbital wall thickness and the spread of infection from the paranasal sinuses. Clin Otolaryngol Allied Sci 1985; 10:209.</a></li><li><a class="nounderline abstract_t">Jackson K, Baker SR. Periorbital cellulitis. Head Neck Surg 1987; 9:227.</a></li><li><a class="nounderline abstract_t">Ganesh A, Venugopalan P. Preseptal orbital cellulitis following oral trauma. J Pediatr Ophthalmol Strabismus 2000; 37:315.</a></li><li><a class="nounderline abstract_t">Smith TF, O'Day D, Wright PF. Clinical implications of preseptal (periorbital) cellulitis in childhood. Pediatrics 1978; 62:1006.</a></li><li><a class="nounderline abstract_t">Hutcheson KA, Magbalon M. Periocular abscess and cellulitis from Pasteurella multocida in a healthy child. Am J Ophthalmol 1999; 128:514.</a></li><li><a class="nounderline abstract_t">Chaudhry IA, Shamsi FA, Elzaridi E, et al. Inpatient preseptal cellulitis: experience from a tertiary eye care centre. Br J Ophthalmol 2008; 92:1337.</a></li><li><a class="nounderline abstract_t">Milstone AM, Ruff AJ, Yeamans C, Higman MA. Pseudomonas aeruginosa pre-septal cellulitis and bacteremia in a pediatric oncology patient. Pediatr Blood Cancer 2005; 45:353; discussion 354.</a></li><li><a class="nounderline abstract_t">Miller J. Acinetobacter as a causative agent in preseptal cellulitis. Optometry 2005; 76:176.</a></li><li><a class="nounderline abstract_t">Mathews D, Mathews JP, Kwartz J, Inkster C. Preseptal cellulitis caused by Acinetobacter lwoffi. Indian J Ophthalmol 2005; 53:213.</a></li><li><a class="nounderline abstract_t">Brannan PA, Kersten RC, Hudak DT, et al. Primary Nocardia brasiliensis of the eyelid. Am J Ophthalmol 2004; 138:498.</a></li><li><a class="nounderline abstract_t">Caça I, Cakmak SS, Unlü K, et al. Cutaneous anthrax on eyelids. Jpn J Ophthalmol 2004; 48:268.</a></li><li><a class="nounderline abstract_t">Raja NS, Singh NN. Bilateral orbital cellulitis due to Neisseria gonorrhoeae and Staphylococcus aureus: a previously unreported case. J Med Microbiol 2005; 54:609.</a></li><li><a class="nounderline abstract_t">Sears JM, Gabriel HM, Veith J. Preseptal cellulitis secondary to Proteus species: a case report and review. J Am Optom Assoc 1999; 70:661.</a></li><li><a class="nounderline abstract_t">Raina UK, Jain S, Monga S, et al. Tubercular preseptal cellulitis in children: a presenting feature of underlying systemic tuberculosis. Ophthalmology 2004; 111:291.</a></li><li><a class="nounderline abstract_t">Velazquez AJ, Goldstein MH, Driebe WT. Preseptal cellulitis caused by trichophyton (ringworm). Cornea 2002; 21:312.</a></li><li><a class="nounderline abstract_t">Upendran MR, McLoone E. Delayed resolution of eyelid swelling in preseptal cellulitis in a child: beware of causing occlusion amblyopia. BMJ Case Rep 2013; 2013.</a></li><li><a class="nounderline abstract_t">Seltz LB, Smith J, Durairaj VD, et al. Microbiology and antibiotic management of orbital cellulitis. Pediatrics 2011; 127:e566.</a></li><li><a class="nounderline abstract_t">Nageswaran S, Woods CR, Benjamin DK Jr, et al. Orbital cellulitis in children. Pediatr Infect Dis J 2006; 25:695.</a></li><li class="breakAll">Durand, ML. Periocular infections. In: Principles and Practice of Infectious Diseases, 7th ed, Mandell, GL, Bennett, JE, Dolin, R (Eds), Churchill Livingstone Elsevier, Philadelphia 2010. p.1569.</li><li><a class="nounderline abstract_t">Sobol SE, Marchand J, Tewfik TL, et al. Orbital complications of sinusitis in children. J Otolaryngol 2002; 31:131.</a></li><li><a class="nounderline abstract_t">Howe L, Jones NS. Guidelines for the management of periorbital cellulitis/abscess. Clin Otolaryngol Allied Sci 2004; 29:725.</a></li><li><a class="nounderline abstract_t">Uzcátegui N, Warman R, Smith A, Howard CW. Clinical practice guidelines for the management of orbital cellulitis. J Pediatr Ophthalmol Strabismus 1998; 35:73.</a></li><li><a class="nounderline abstract_t">Sorin A, April MM, Ward RF. Recurrent periorbital cellulitis: an unusual clinical entity. Otolaryngol Head Neck Surg 2006; 134:153.</a></li><li><a class="nounderline abstract_t">Karkos PD, Karagama Y, Karkanevatos A, Srinivasan V. Recurrent periorbital cellulitis in a child. A random event or an underlying anatomical abnormality? Int J Pediatr Otorhinolaryngol 2004; 68:1529.</a></li></ol></div><div id="topicVersionRevision">Topic 16650 Version 35.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10919886" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18191234" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Paediatric pre- and post-septal peri-orbital infections are different diseases. A retrospective review of 262 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4053422" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Orbital wall thickness and the spread of infection from the paranasal sinuses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3312114" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Periorbital cellulitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11020118" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Preseptal orbital cellulitis following oral trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/310537" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Clinical implications of preseptal (periorbital) cellulitis in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10577599" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Periocular abscess and cellulitis from Pasteurella multocida in a healthy child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18697809" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Inpatient preseptal cellulitis: experience from a tertiary eye care centre.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15926173" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Pseudomonas aeruginosa pre-septal cellulitis and bacteremia in a pediatric oncology patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15786636" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Acinetobacter as a causative agent in preseptal cellulitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16137978" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Preseptal cellulitis caused by Acinetobacter lwoffi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15364245" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Primary Nocardia brasiliensis of the eyelid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15175920" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Cutaneous anthrax on eyelids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15888472" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Bilateral orbital cellulitis due to Neisseria gonorrhoeae and Staphylococcus aureus: a previously unreported case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10561925" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Preseptal cellulitis secondary to Proteus species: a case report and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15019377" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Tubercular preseptal cellulitis in children: a presenting feature of underlying systemic tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11917183" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Preseptal cellulitis caused by trichophyton (ringworm).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23476010" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Delayed resolution of eyelid swelling in preseptal cellulitis in a child: beware of causing occlusion amblyopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21321025" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Microbiology and antibiotic management of orbital cellulitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16874168" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Orbital cellulitis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16874168" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Orbital cellulitis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12121013" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Orbital complications of sinusitis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15533168" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Guidelines for the management of periorbital cellulitis/abscess.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9559505" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Clinical practice guidelines for the management of orbital cellulitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16399197" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Recurrent periorbital cellulitis: an unusual clinical entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15533566" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Recurrent periorbital cellulitis in a child. A random event or an underlying anatomical abnormality?</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
